The first batch of the Russian vaccine against COVID-19, which was developed by the Gamaleya Research Institute of Epidemiology and Microbiology and passed all laboratory tests, has been released for public use, according to the Russian Health Ministry’s press service.
It means that the vaccination of the population from risk groups, in particular doctors and teachers, is to begin. Immunization will run in parallel with post-registration clinical trials.
The first batches of vaccine are to be delivered to the Russian regions shortly.
During the trials, Sputnik V formed a stable humoral and cellular immune response in all volunteers.
NEWS.ru earlier reported that Russian specialists plan to complete the post-registration stage (the third one) of the Sputnik V anti-COVID vaccine trials before December 31, 2022.